Filter
1737
Text search:
antiretroviral
therapy
Featured
190
545
Language
Document type
1043
257
224
62
43
41
36
8
8
5
4
2
1
Countries
85
67
61
57
55
45
42
40
37
37
34
31
30
29
29
28
25
25
24
23
23
22
17
15
15
14
13
12
12
11
11
10
9
9
9
8
7
6
5
5
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
831
158
96
64
44
40
18
1
Toolboxes
308
266
43
43
36
34
23
22
21
20
18
18
17
17
13
8
7
7
6
4
4
2
1
Review
S Afr Med J 2014;104(3):174-177. DOI: 10.7196/SAMJ.7968
Policy Guidelines for Health Facilities
Kenya: Guidelines on use of antiretroviral drugs for treating and preventing HIV infection
recommended
2018 Edition
Regulation of the Minister of Health of the Republic of Indonesia on Guidelines for Antiretroviral Treatment
PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
Thirty-three years after its discovery, the Human Immunodeficiency Virus (HIV), responsible for the AIDS pandemic, remains a major public health problem despite advanced researches providing better diagnostic and therapeutic tools. The virus targets especially CD4+ T cells, leading to deficiency of
...
Version: 14 March 2019; A one-page reference guide to all the anti-HIV drugs licensed for use in the European Union, with information on formulation, dosing, key side-effects and food restrictions.
The previous edition of the drugs chart is also available to download in Russian.
Programmatic update
April 2012
Executive Summary
Moving avidence into action
This document is part of a series of briefs for health program managers interested in implementing evidence-based programs. With a special emphasis on underutilized interventions, they present evidence on programs that work and provide guidance and resources for replicat
...
HIV/TB Research Meeting; March 3, 2013
PLOS ONE | DOI:10.1371/journal.pone.0155525 May 19, 2016, 1 / 11
Research Article
BMC Infectious Diseases 2014, 14:91/1471-2334/14/91
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica
...